Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 597.82% and ...

As Eli Lilly and Novo Nordisk continue to dominate the lucrative weight-loss drug market, smaller competitors are gearing up ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...

according to the company’s website. Most U.S. patients are covered by health insurance and would likely pay less for the drugs. Novo and rival Eli Lilly, which makes the weight loss drug Zepbound, ...

Almirall has rolled out a new campaign for World Atopic Eczema Day, kicking off its “The T | Almirall has rolled out a new ...

New educational tool will help companies assess how well their health and well-being programs support their workforce’s brain ...

While Cork is already successful in the production of industry winners, Eli Lilly's obesity and weight loss drugs are ...

One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a ...

Nordic biotech company Pila Pharma, founded and chaired by former Novo Nordisk researcher Dorte X. Gram, has recently raised 10 million SEK in directed issue for a novel obesity-related study.An ...